AMW GmbH from Warngau continues to grow and establishes an advisory board
More than 100 people are now employed at the pharmaceutical plant in Warngau. In addition to the implants Goserelin and Leuprorelin and the patches Buprenorphin and Rivastigmine, the specialty pharmaceutical company developed a generic version of MSD’s Nuvaring contraceptive ring to market maturity. AMW is thus setting new standards in contraception. In order to improve its scientific and technical position, AMW has established an advisory board consisting of Dr. Georg Ingram, Dr. Dirk Schrader and Prof. Dr. Gerhard Winter.
Dezember 2019
Meanwhile more than 100 employees are employed at the pharmaceutical companyin Warngau. The specialy pharmaceuticalwas able to develop a generic drug for the contraception ring Nuvaring of MSD to market maturityin addition to the implants Goserelin and Leuprorelin as well as patches Buprenorphin and Rivastigmin,. With this product, AMW is setting new standards in contraception. Furthermorenew products are under development. In order to position itself even better scientifically and technically, AMW founds an advisory board consisting of Dr. Georg Ingram, Dr. Dirk Schrader and Prof. Dr. Gerhard Winter.
AMW has founded an advisory board with top-class members. The advisory board is intended to support the specialty pharmaceutical company based south of Munich with specific technical challenges and in the decision-making process for strategic questions. In the following the advisory board, consisting of Dr. Georg Ingram, Dr. Dirk Schrader and Prof. Dr. Gerhard Winter, is presented in more detail.
Dr. Georg Ingram is an expert in business development, licensing and project management. With more than 20 years of experience in various companies, such as Pharmascience Inc, Actavis and Alvogen, he enriches the pharmaceutical industry with diverse background knowledge.
Executive Vice President and Head of Technical Operations at Vifor Pharma is Dr. Dirk Schrader. Previously, he worked for Bayer, Bristol-Myers Squibb and AstraZeneca and brings a wealth of Asian market experience and leadership skills. With his experience and pharmaceutical knowledge, he will also support AMW in technical matters.
Prof. Dr. Gerhard Winter, Professor of Pharmaceutical Technologies and Biopharmaceutics, has been working with parenteral medication systems since 1988. Duringhis career, he pursued the development of products in particular and acquireda wide range of knowledgein the fieldof development. As an expert in this field, he will assist AMW with his advice on specific questions.
The management of AMW and the advisory board are looking forward to the cooperation.
Prof. Dr. Gerhard Winter 
Dr. George Ingram 
Dr. Dirk Schrader